Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHBY)

Delayed Data
As of Nov 17
 +0.205 / +0.71%
Today’s Change
Today|||52-Week Range
Pfizer's Cancer Drug Sutent Gets FDA Nod for Label Expansion
Nov 17 / Zacks.com - Paid Partner Content
Shire Gets Positive CHMP Opinion for Hemophilia A Drug
Nov 14 / Zacks.com - Paid Partner Content
Cancer Space Update: Label Expansion for Three Major Drugs
Nov 17 / Zacks.com - Paid Partner Content
Novartis (NVS) Arm's Biosimilars Study Results Encourage
Nov 14 / Zacks.com - Paid Partner Content
Roche's (RHHBY) Hemophilia A Drug Receives FDA Approval
Nov 17 / Zacks.com - Paid Partner Content
Nektar/Bristol-Myers' Combo Trial Positive in Phase I/II
Nov 13 / Zacks.com - Paid Partner Content
Why is Alnylam's (ALNY) Stock Up More Than 200% this Year?
Nov 16 / Zacks.com - Paid Partner Content
Amgen Gets Positive CHMP Opinion to Expand Nplate's Label
Nov 13 / Zacks.com - Paid Partner Content
Roche (RHHBY) Receives FDA Clearance for Ventana MMR Test
Nov 15 / Zacks.com - Paid Partner Content
Merck KGaA (MKGAF) Q3 Earnings Decline Y/Y, Revenues Flat
Nov 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close28.90
Today’s open28.98
Day’s range28.91 - 29.10
Average volume (3 months)1,342,280
Market cap$161.4B
Dividend yield3.53%
Data as of 3:59pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)+5.44%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.29%
Revenue growth (last year)+2.58%
P/E ratio--


No competitors data available.


Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$51.3B
Annual profit (last year)$9.7B
Net profit margin18.93%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
Chief Financial &
Information Technology Officer
Alan Hippe
Corporate headquarters
Basel, Basel-stadt (basle Town)